Sintropium [VAL 480] is a gastrointestinal, biliary and urinary spasmolytic agent that was under development with Valeas in Italy. It is a muscarinic receptor antagonist. Sintropium bromide has a prompt anticholinergic action and for this reason may be used in the treatment of painful conditions of the bile, gastro-enteric and renal tracts, and also during the course of endoscopic examinations.

Etanterol (VAL 481), a phenethanolamine derivative, is a β2 adrenoceptor agonist that was undergoing phase II trials in Italy as a bronchodilator with Valeas.

Naminterol [VAL 479], a phenethanolamine derivative, is a β2 adrenoceptor agonist with bronchodilatory properties. The compound was undergoing phase II clinical trials for asthma in Italy.

Sintropium [VAL 480] is a gastrointestinal, biliary and urinary spasmolytic agent that was under development with Valeas in Italy. It is a muscarinic receptor antagonist. Sintropium bromide has a prompt anticholinergic action and for this reason may be used in the treatment of painful conditions of the bile, gastro-enteric and renal tracts, and also during the course of endoscopic examinations.